Alpha Teknova, Inc.
TKNO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001850902
No open-market purchases or sales by Alpha Teknova, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $51.7M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Alpha Teknova, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +5 vs. Q2 2024
- Shares held
- 5.14M
- −679.2K (−11.7%) vs. Q2 2024
- Total value
- $24.9M
- +$16.9M (+211.8%) vs. Q2 2024
- New holders
- 11
- 11 more added
- Sold out
- 6
- 9 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TKNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $51.7M |
| Q1 2026 | 78 | $22.1M |
| Q4 2025 | 70 | $26.6M |
| Q3 2025 | 67 | $45.9M |
| Q2 2025 | 68 | $37.6M |
| Q1 2025 | 65 | $32.0M |
| Q4 2024 | 47 | $53.2M |
| Q3 2024 | 32 | $24.9M |
| Q2 2024 | 28 | $8.03M |
| Q1 2024 | 31 | $15.6M |
| Q4 2023 | 31 | $21.0M |
| Q3 2023 | 28 | $14.5M |
| Q2 2023 | 31 | $12.0M |
| Q1 2023 | 44 | $16.3M |
| Q4 2022 | 47 | $30.2M |
| Q3 2022 | 54 | $21.3M |
| Q2 2022 | 52 | $58.1M |
| Q1 2022 | 51 | $95.3M |
| Q4 2021 | 52 | $146.3M |
| Q3 2021 | 52 | $178.0M |
| Q2 2021 | 50 | $153.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Alpha Teknova, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 451 | $2.18K | 0.00% | −5,831−92.8% | Reduced |
| JPMorgan Chase & Co | 609 | $2.95K | 0.00% | +526+633.7% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 1,942 | $9.40K | 0.00% | +1,942 | New |
| Two Sigma Investments, LP | 10,359 | $50.1K | 0.00% | +10,359 | New |
| Citadel Advisors LLC | 10,382 | $50.2K | 0.00% | +270+2.7% | Added |
| Cubist Systematic Strategies, LLC | 13,327 | $64.5K | 0.00% | +13,327 | New |
| GWM Advisors LLC | 13,679 | $66.2K | 0.00% | +13,679 | New |
| Marshall Wace, LLP | 16,216 | $78.5K | 0.00% | +16,216 | New |
| Dimensional Fund Advisors LP | 17,855 | $86.1K | 0.00% | −1,271−6.6% | Reduced |
| Jefferies Financial Group Inc. | 22,400 | $108.4K | 0.00% | +22,400 | New |
| Qube Research & Technologies Ltd | 24,148 | $116.9K | 0.00% | +24,121+89,337.0% | Added |
| Squarepoint Ops LLC | 28,597 | $138.4K | 0.00% | +28,597 | New |
| Northern Trust Corp | 29,813 | $144.3K | 0.00% | −617−2.0% | Reduced |
| Morgan Stanley | 35,984 | $174.2K | 0.00% | −8,766−19.6% | Reduced |
| Susquehanna International Group, LLP | 36,581 | $177.1K | 0.00% | −30,960−45.8% | Reduced |
| Fielder Capital Group LLC | 41,849 | $202.5K | 0.07% | 00.0% | Unchanged |
| Citigroup Inc | 45,055 | $218.1K | 0.00% | +44,771+15,764.4% | Added |
| BlackRock, Inc. | 74,095 | $358.6K | 0.00% | +74,095 | New |
| State Street Corp | 76,645 | $371.0K | 0.00% | +54,700+249.3% | Added |
| Renaissance Technologies LLC | 86,000 | $416.2K | 0.00% | +86,000 | New |
| FourWorld Capital Management LLC | 95,000 | $459.8K | 0.43% | +43,973+86.2% | Added |
| Bridgeway Capital Management, LLC | 110,000 | $532.4K | 0.01% | +50,000+83.3% | Added |
| Geode Capital Management, LLC | 188,173 | $911.1K | 0.00% | +36,914+24.4% | Added |
| Bank of America Corp | 217,381 | $1.05M | 0.00% | +1,005+0.5% | Added |
| Parkman Healthcare Partners LLC | 251,026 | $1.21M | 0.16% | −45,626−15.4% | Reduced |
| Conestoga Capital Advisors, LLC | 305,129 | $1.48M | 0.02% | −148,770−32.8% | Reduced |
| Point72 Asset Management, L.P. | 306,427 | $1.48M | 0.01% | +306,427 | New |
| Schonfeld Strategic Advisors LLC | 366,400 | $1.77M | 0.01% | +325,573+797.4% | Added |
| Roubaix Capital, LLC | 416,416 | $2.02M | 1.11% | +416,416 | New |
| Vanguard Group Inc | 560,860 | $2.71M | 0.00% | +7,379+1.3% | Added |
| Millennium Management LLC | 737,215 | $3.57M | 0.00% | −1,109,185−60.1% | Reduced |
| Balyasny Asset Management LLC | 1,000,090 | $4.84M | 0.01% | −45,579−4.4% | Reduced |
| Platinum Investment Management Ltd | 0 | $0 | 0.00% | −531,414−100.0% | Sold out |
| Osterweis Capital Management Inc | 0 | $0 | 0.00% | −155,170−100.0% | Sold out |
| Redmile Group, LLC | 0 | $0 | 0.00% | −154,509−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −12,003−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −8,075−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −123−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |